Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.22.2.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 22,277 $ 24,983
Marketable securities, current 57,168 118,061
Prepaid expenses 3,729 3,917
Other current assets 4,011 1,254
Total current assets 87,185 148,215
Marketable securities, non-current 0 8,986
Operating lease right-of-use assets 11,120 8,608
Property and equipment, net 16,347 19,309
Other assets 3,994 7,244
Total assets 118,646 192,362
Current liabilities:    
Accounts payable 1,085 1,612
Accrued liabilities 8,890 9,515
Deferred revenue, current 38,290 32,937
Other current liabilities 1,957 2,606
Total current liabilities 50,222 46,670
Deferred revenue, long-term 14,641 33,350
Long-term debt, net of current portion 35,940 35,491
Operating lease liabilities 12,422 9,564
Other liabilities 1,269 1,625
Total liabilities 114,494 126,700
Commitments and contingencies (Note 10) 0 0
Stockholders’ equity    
Preferred stock, $0.001 par value: Authorized: 2,000,000 shares at June 30, 2022 and December 31, 2021; issued and outstanding: 250 shares at June 30, 2022 and December 31, 2021 0 0
Common stock, $0.001 par value: Authorized: 150,000,000 shares at September 30, 2022 and December 31, 2021; issued and outstanding: 56,351,647 shares at September 30, 2022 and 56,305,049 shares at December 31, 2021 56 56
Additional paid-in capital 427,042 417,704
Accumulated other comprehensive loss (227) (48)
Accumulated deficit (422,719) (352,050)
Total stockholders’ equity 4,152 65,662
Total liabilities and stockholders’ equity $ 118,646 $ 192,362